Whiteoak Capital Pharma and Healthcare Fund - Regular Plan - Growth vs Nippon India Nifty Pharma ETF - Growth Plan
NAV, returns and costs — not a recommendation.
 Whiteoak Capital Pharma and Healthcare Fund - Regular Plan - Growth |  Nippon India Nifty Pharma ETF - Growth Plan | |
|---|---|---|
| NAV | ₹16.823 | ₹27.1122 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.79% | +19.49% |
| 3 year (p.a.) | +22.83% | +20.35% |
| 5 year (p.a.) | +22.83% | +14.55% |
| Expense ratio | 2.05% | 0.18% |
| Fund size | ₹664.02 Cr | ₹1,622.31 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Etfs |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.